Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Factors accounting for excess uterine cancer mortality among insured Black versus White patients treated within the same US health care system.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 20, 2025
Locally-tailored vs. centrally-administered strategies for implementation of primary human papillomavirus (HPV) screening in an integrated healthcare system: a qualitative research study.
Journal: Frontiers in health services
Published: March 18, 2025
Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System.
Journal: JCO oncology practice
Published: February 28, 2025
A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare system.
Journal: Implementation science : IS
Published: November 21, 2024
Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone.
Journal: The Permanente journal
Published: October 24, 2024
Racial and Ethnic Disparities in the Time to Ovarian Cancer Surgery in Patients at an Integrated Health Care Delivery System.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 16, 2024
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations.
Journal: Journal of women's health (2002)
Published: September 11, 2024
Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California.
Journal: American journal of obstetrics and gynecology
Published: September 09, 2024
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system.
Journal: Contemporary clinical trials
Published: March 04, 2022
De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening.
Journal: Implementation science communications
Published: March 19, 2021
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020.
Journal: MMWR. Morbidity and mortality weekly report
Published: January 28, 2021
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Journal: The Lancet. Oncology
Published: June 18, 2020
Last Updated: 09/26/2026